ANTITRUST-9th Cir.: Invisalign® manufacturer must face refusal to deal allegations (Oct 6, 2026)
Originally at news.google.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
DSO and private-practice owners who rely on Invisalign® or comparable clear-aligner systems face potential supply-chain or pricing shifts if Align Technology is forced to sell to competing labs or providers under the 9th Circuit’s refusal-to-deal ruling.
Key points
- The 9th Circuit reinstated antitrust claims against Align Technology, maker of Invisalign®, holding that refusal-to-deal allegations may proceed to trial.
- The decision could open the door for third-party labs or smaller DSOs to obtain Invisalign®-compatible materials or manufacturing rights they were previously denied.
- Practices that currently purchase Align’s full-service workflow (scanner, software, aligners) may see new vendor options or pricing pressure if competitors gain access.
- Align Technology remains subject to ongoing litigation; no immediate supply or pricing changes have been ordered.
Who should care
Read the original on Media: DSOs & private equity
Full reporting and any paywall content live on news.google.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Taylor dentist faces two felony drug charges after police say he was selling meth at Canton Township home
- ·Regulatory
Is fluoride still safe for kids? A dentist breaks down what the research actually shows
- ·Regulatory
New California law requires dental insurers to pay out-of-network dentists directly
- ·Regulatory
Privacy Act of 1974; Matching Program